Citadel Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Citadel Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,300	Closed	-$444K	–	14030
2025 Q3	$444K	Sell	9,300 -2,100	-18%	-$84.6K	﹤0.01%	9431
2025 Q2	$359K	Buy	11,400 +2,600	+30%	+$83.3K	﹤0.01%	9390
2025 Q1	$288K	Sell	8,800 -3,300	-27%	-$117K	﹤0.01%	9694
2024 Q4	$438K	Sell	12,100 -2,900	-19%	-$102K	﹤0.01%	8853
2024 Q3	$468K	Buy	15,000 +4,400	+42%	+$137K	﹤0.01%	8406
2024 Q2	$284K	Buy	10,600 +2,300	+28%	+$66.7K	﹤0.01%	9253
2024 Q1	$283K	Buy	8,300 +700	+9%	+$20.8K	﹤0.01%	9579
2023 Q4	$220K	Buy	7,600 +1,700	+29%	+$45.1K	﹤0.01%	9756
2023 Q3	$163K	Sell	5,900 -4,100	-41%	-$125K	﹤0.01%	10228
2023 Q2	$301K	Buy	10,000 +3,400	+52%	+$119K	﹤0.01%	9046
2023 Q1	$239K	Sell	6,600 -1,000	-13%	-$38.5K	﹤0.01%	9846
2022 Q4	$271K	Buy	+7,600	New	+$264K	﹤0.01%	9538
2022 Q3	–	Sell	-12,100	Closed	-$350K	–	13572
2022 Q2	$350K	Sell	12,100 -2,500	-17%	-$71.6K	﹤0.01%	9465
2022 Q1	$472K	Sell	14,600 -21,600	-60%	-$662K	﹤0.01%	9530
2021 Q4	$1.06M	Buy	36,200 +13,800	+62%	+$419K	﹤0.01%	7815
2021 Q3	$597K	Sell	22,400 -4,800	-18%	-$129K	﹤0.01%	9429
2021 Q2	$837K	Sell	27,200 -3,500	-11%	-$107K	﹤0.01%	8822
2021 Q1	$804K	Buy	30,700 +16,300	+113%	+$456K	﹤0.01%	8632
2020 Q4	$362K	Buy	+14,400	New	+$310K	﹤0.01%	8751
2020 Q3	–	Sell	-30,100	Closed	-$715K	–	10706
2020 Q2	$715K	Buy	30,100 +7,500	+33%	+$166K	﹤0.01%	6438
2020 Q1	$407K	Buy	+22,600	New	+$475K	﹤0.01%	6803
2019 Q4	–	Sell	-25,300	Closed	-$695K	–	9740
2019 Q3	$695K	Buy	25,300 +14,000	+124%	+$415K	﹤0.01%	6200
2019 Q2	$374K	Sell	11,300 -7,300	-39%	-$250K	﹤0.01%	7254
2019 Q1	$652K	Buy	18,600 +3,200	+21%	+$119K	﹤0.01%	6342
2018 Q4	$512K	Sell	15,400 -9,300	-38%	-$400K	﹤0.01%	6352
2018 Q3	$1.24M	Buy	24,700 +13,200	+115%	+$652K	﹤0.01%	5169
2018 Q2	$688K	Sell	11,500 -9,000	-44%	-$466K	﹤0.01%	5855
2018 Q1	$939K	Buy	20,500 +200	+1%	+$8.35K	﹤0.01%	4918
2017 Q4	$809K	Sell	20,300 -6,500	-24%	-$257K	﹤0.01%	4959
2017 Q3	$1.07M	Buy	26,800 +7,900	+42%	+$342K	﹤0.01%	4215
2017 Q2	$815K	Sell	18,900 -5,600	-23%	-$199K	﹤0.01%	4391
2017 Q1	$767K	Buy	24,500 +12,600	+106%	+$338K	﹤0.01%	4391
2016 Q4	$300K	Buy	11,900 +1,000	+9%	+$22.3K	﹤0.01%	5669
2016 Q3	$270K	Sell	10,900 -3,700	-25%	-$83.7K	﹤0.01%	5850
2016 Q2	$297K	Sell	14,600 -3,600	-20%	-$63.9K	﹤0.01%	5234
2016 Q1	$278K	Buy	18,200 +12,500	+219%	+$163K	﹤0.01%	5196
2015 Q4	$77K	Sell	5,700 -3,600	-39%	-$55.7K	﹤0.01%	6946
2015 Q3	$130K	Sell	9,300 -600	-6%	-$11.2K	﹤0.01%	6683
2015 Q2	$168K	Sell	9,900 -5,400	-35%	-$76.9K	﹤0.01%	6533
2015 Q1	$185K	Buy	15,300 +11,700	+325%	+$111K	﹤0.01%	6270
2014 Q4	$30K	Sell	3,600 -4,900	-58%	-$41.2K	﹤0.01%	7557
2014 Q3	$74K	Buy	8,500 +5,900	+227%	+$53.3K	﹤0.01%	6644
2014 Q2	$28K	Sell	2,600 -2,000	-43%	-$17.8K	﹤0.01%	7119
2014 Q1	$41K	Buy	4,600 +2,000	+77%	+$18.4K	﹤0.01%	6900
2013 Q4	$20K	Sell	2,600 -55,200	-96%	-$386K	﹤0.01%	6458
2013 Q3	$424K	Sell	57,800 -28,500	-33%	-$191K	﹤0.01%	3977
2013 Q2	$555K	Buy	+86,300	New	+$508K	﹤0.01%	3743